The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Fatigue Syndrome, Chronic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Fatigue Syndrome, Chronic


Psychiatry related information on Fatigue Syndrome, Chronic


High impact information on Fatigue Syndrome, Chronic


Chemical compound and disease context of Fatigue Syndrome, Chronic


Biological context of Fatigue Syndrome, Chronic


Anatomical context of Fatigue Syndrome, Chronic


Gene context of Fatigue Syndrome, Chronic


Analytical, diagnostic and therapeutic context of Fatigue Syndrome, Chronic


  1. Absence of parvovirus B19 infection in chronic fatigue syndrome. Ilaria, R.L., Komaroff, A.L., Fagioli, L.R., Moloney, W.C., True, C.A., Naides, S.J. Arthritis Rheum. (1995) [Pubmed]
  2. Ureaplasma urealyticum and Mycoplasma hominis in women with systemic lupus erythematosus. Ginsburg, K.S., Kundsin, R.B., Walter, C.W., Schur, P.H. Arthritis Rheum. (1992) [Pubmed]
  3. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Blockmans, D., Persoons, P., Van Houdenhove, B., Lejeune, M., Bobbaers, H. Am. J. Med. (2003) [Pubmed]
  4. Neuropathology in rhinosinusitis. Baraniuk, J.N., Petrie, K.N., Le, U., Tai, C.F., Park, Y.J., Yuta, A., Ali, M., Vandenbussche, C.J., Nelson, B. Am. J. Respir. Crit. Care Med. (2005) [Pubmed]
  5. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Bearn, J., Allain, T., Coskeran, P., Munro, N., Butler, J., McGregor, A., Wessely, S. Biol. Psychiatry (1995) [Pubmed]
  6. A new view on hypocortisolism. Fries, E., Hesse, J., Hellhammer, J., Hellhammer, D.H. Psychoneuroendocrinology (2005) [Pubmed]
  7. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Nishikai, M., Tomomatsu, S., Hankins, R.W., Takagi, S., Miyachi, K., Kosaka, S., Akiya, K. Rheumatology (Oxford, England) (2001) [Pubmed]
  8. Decreased fractal correlation in diurnal physical activity in chronic fatigue syndrome. Ohashi, K., Bleijenberg, G., van der Werf, S., Prins, J., Amaral, L.A., Natelson, B.H., Yamamoto, Y. Methods of information in medicine. (2004) [Pubmed]
  9. The development of the Chronic Fatigue Syndrome Attitudes Test. A psychometric analysis. Shlaes, J.L., Jason, L.A., Ferrari, J.R. Evaluation & the health professions. (1999) [Pubmed]
  10. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. Wheatland, R. Med. Hypotheses (2005) [Pubmed]
  11. Low-dose hydrocortisone for chronic fatigue syndrome. Baschetti, R. JAMA (1999) [Pubmed]
  12. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. Konstantinov, K., von Mikecz, A., Buchwald, D., Jones, J., Gerace, L., Tan, E.M. J. Clin. Invest. (1996) [Pubmed]
  13. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Vercoulen, J.H., Swanink, C.M., Zitman, F.G., Vreden, S.G., Hoofs, M.P., Fennis, J.F., Galama, J.M., van der Meer, J.W., Bleijenberg, G. Lancet (1996) [Pubmed]
  14. Interleukin-2 and the chronic fatigue syndrome. Cheney, P.R., Dorman, S.E., Bell, D.S. Ann. Intern. Med. (1989) [Pubmed]
  15. Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. Demettre, E., Bastide, L., D'Haese, A., De Smet, K., De Meirleir, K., Tiev, K.P., Englebienne, P., Lebleu, B. J. Biol. Chem. (2002) [Pubmed]
  16. Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Piche, T., Vanbiervliet, G., Cherikh, F., Antoun, Z., Huet, P.M., Gelsi, E., Demarquay, J.F., Caroli-Bosc, F.X., Benzaken, S., Rigault, M.C., Renou, C., Rampal, P., Tran, A. Gut (2005) [Pubmed]
  17. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Peterson, P.K., Pheley, A., Schroeppel, J., Schenck, C., Marshall, P., Kind, A., Haugland, J.M., Lambrecht, L.J., Swan, S., Goldsmith, S. Arch. Intern. Med. (1998) [Pubmed]
  18. Treatment of chronic fatigue syndrome with nefazodone. Goodnick, P.J., Jorge, C.M. The American journal of psychiatry. (1999) [Pubmed]
  19. Use of amantadine for chronic fatigue syndrome. Bowman, M.A., Kirk, J.K., Michielutte, R., Preisser, J.S. Arch. Intern. Med. (1997) [Pubmed]
  20. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Suhadolnik, R.J., Reichenbach, N.L., Hitzges, P., Sobol, R.W., Peterson, D.L., Henry, B., Ablashi, D.V., Müller, W.E., Schröder, H.C., Carter, W.A. Clin. Infect. Dis. (1994) [Pubmed]
  21. Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy. Williams, G., Waterhouse, J., Mugarza, J., Minors, D., Hayden, K. Eur. J. Clin. Invest. (2002) [Pubmed]
  22. Fractal analysis and recurrence quantification analysis of heart rate and pulse transit time for diagnosing chronic fatigue syndrome. Naschitz, J.E., Sabo, E., Naschitz, S., Rosner, I., Rozenbaum, M., Priselac, R.M., Gaitini, L., Zukerman, E., Yeshurun, D. Clin. Auton. Res. (2002) [Pubmed]
  23. Dissociation of body-temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome. Williams, G., Pirmohamed, J., Minors, D., Waterhouse, J., Buchan, I., Arendt, J., Edwards, R.H. Clinical physiology (Oxford, England) (1996) [Pubmed]
  24. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. Strickland, P., Morriss, R., Wearden, A., Deakin, B. Journal of affective disorders. (1998) [Pubmed]
  25. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Evengard, B., Nilsson, C.G., Lindh, G., Lindquist, L., Eneroth, P., Fredrikson, S., Terenius, L., Henriksson, K.G. Pain (1998) [Pubmed]
  26. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. Linde, A., Andersson, B., Svenson, S.B., Ahrne, H., Carlsson, M., Forsberg, P., Hugo, H., Karstorp, A., Lenkei, R., Lindwall, A. J. Infect. Dis. (1992) [Pubmed]
  27. Immunological abnormalities in the chronic fatigue syndrome. Lloyd, A.R., Wakefield, D., Boughton, C.R., Dwyer, J.M. Med. J. Aust. (1989) [Pubmed]
  28. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Regland, B., Andersson, M., Abrahamsson, L., Bagby, J., Dyrehag, L.E., Gottfries, C.G. Scand. J. Rheumatol. (1997) [Pubmed]
  29. Cytokines in nasal lavage fluids from acute sinusitis, allergic rhinitis, and chronic fatigue syndrome subjects. Repka-Ramirez, S., Naranch, K., Park, Y.J., Clauw, D., Baraniuk, J.N. Allergy and asthma proceedings : the official journal of regional and state allergy societies. (2002) [Pubmed]
  30. Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome. Shetzline, S.E., Martinand-Mari, C., Reichenbach, N.L., Buletic, Z., Lebleu, B., Pfleiderer, W., Charubala, R., De Meirleir, K., De Becker, P., Peterson, D.L., Herst, C.V., Englebienne, P., Suhadolnik, R.J. J. Interferon Cytokine Res. (2002) [Pubmed]
  31. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Scott, L.V., Medbak, S., Dinan, T.G. Acta psychiatrica Scandinavica. (1998) [Pubmed]
  32. Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS. Maes, M., Mihaylova, I., De Ruyter, M. Neuro Endocrinol. Lett. (2005) [Pubmed]
  33. Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Allain, T.J., Bearn, J.A., Coskeran, P., Jones, J., Checkley, A., Butler, J., Wessely, S., Miell, J.P. Biol. Psychiatry (1997) [Pubmed]
  34. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Altemus, M., Dale, J.K., Michelson, D., Demitrack, M.A., Gold, P.W., Straus, S.E. Psychoneuroendocrinology (2001) [Pubmed]
  35. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Cleare, A.J., Miell, J., Heap, E., Sookdeo, S., Young, L., Malhi, G.S., O'Keane, V. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  36. Reduction of serotonin transporters of patients with chronic fatigue syndrome. Yamamoto, S., Ouchi, Y., Onoe, H., Yoshikawa, E., Tsukada, H., Takahashi, H., Iwase, M., Yamaguti, K., Kuratsune, H., Watanabe, Y. Neuroreport (2004) [Pubmed]
  37. Prognosis of chronic fatigue in a community-based sample. Taylor, R.R., Jason, L.A., Curie, C.J. Psychosomatic medicine. (2002) [Pubmed]
  38. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. Schwartz, R.B., Garada, B.M., Komaroff, A.L., Tice, H.M., Gleit, M., Jolesz, F.A., Holman, B.L. AJR. American journal of roentgenology. (1994) [Pubmed]
  39. Frequency of deviant immunological test values in chronic fatigue syndrome patients. Natelson, B.H., Ellis, S.P., Braonáin, P.J., DeLuca, J., Tapp, W.N. Clin. Diagn. Lab. Immunol. (1995) [Pubmed]
WikiGenes - Universities